510(k) Report

FDA applicant

Intera Oncology, Inc.

Wellesley, MA4 decisions1982–202215 recalls

FDA records 4 decisions for Intera Oncology, Inc. (Wellesley, MA) from 1982 to 2022: 2 510(k) clearances and 2 original PMA approvals. Most are in product codes PTI (Non-Coring (Huber) Needle) and LKK (Pump, Infusion, Implanted, Programmable). Its devices cite 1 predicate, 0 of them its own earlier devices. 15 recalls are linked to its devices, 11 Class I.

FDA’s records also spell it “Intera Oncology”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Intera Oncology, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2021: 12022: 1
2007high 1 (2021) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2026

2013: 10, 10 Class I2015: 32022: 1, 1 Class I2026 (partial year): 1
2007high 10 (2013) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Intera Oncology, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Intera Oncology, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Intera”

FDA records each applicant name separately; these may or may not be the same firm.